Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Related posts
-
‘It’s a castle’: Dan and Ada Rice’s legacy lives on in revamped Danada House
The newly refurbished Danada House has reopened after a roughly $6.5 million project. -
Baseball: Hersey upsets Fremd in MSL title game
It was all about the arms for Hersey Friday in Palatine. -
Mount Prospect seeking developers for former Chase Bank property
Mount Prospect is moving forward with plans to redevelopment of the former Chase Bank property at...